Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FH5FS
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,158
Award facts
- Contract value 100% obligated
- $49,158.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
On September 29, 2025, the Defense Logistics Agency awarded a firm fixed-price delivery order valued at $49,158.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, contract number 4569644922, is for the supply of Entyvio 300 mg vials, a biologic pharmaceutical product used in the treatment of inflammatory bowel disease. The contract carries an ultimate completion date of October 21, 2025, and the place of performance is Park Ridge, Illinois. No set-aside designation was applied to this award.
This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, which is valued at $499,999,999 and remains valid through November 2026. As a prime contractor on this overarching IDC, DMS Pharmaceutical Group serves as a critical supplier in the federal pharmaceutical supply chain, distributing prescription medications, biologics, and medical consumables to Department of Defense healthcare facilities nationwide. The company's established position as a pharmaceutical wholesaler with consistent federal contracting experience positions it to efficiently fulfill the specialized pharmaceutical requirements of military health systems.
Quick answers
Who was awarded contract SPE2DB25FH5FS?
SPE2DB25FH5FS was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 29, 2025.
How much is contract SPE2DB25FH5FS worth?
The government has obligated $49,158 on SPE2DB25FH5FS.
Is contract SPE2DB25FH5FS an order under another contract?
Yes. SPE2DB25FH5FS is a delivery order under SPE2DB22D9207, an indefinite delivery contract.
Was contract SPE2DB25FH5FS competed?
The extent of competition for SPE2DB25FH5FS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award